Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Pharmac seeks public feedback to simplify access to funded medicines in rare cases, aiming for clearer, more transparent processes.
Pharmac is seeking public input to simplify and clarify its framework for accessing funded medicines in exceptional clinical cases, where standard rules don’t apply.
The current process, which includes pathways like Named Patient Assessments and Special Authority waivers, has been criticized for being confusing, with unclear criteria for “exceptional” cases, opaque decision-making, and poor communication.
Director Adrienne Martin says the goal is to make the system more transparent, consistent, and user-friendly without changing existing processes or approvals.
A two-stage review will begin with feedback on the current framework, followed by a later consultation on potential improvements.
The existing application process will remain unchanged during the review.
Pharmac busca la retroalimentación pública para simplificar el acceso a medicamentos financiados en casos raros, con el objetivo de procesos más claros y transparentes.